Agreement signedAgreed 14 Jul 2026

Glucotrack, Inc. /
Lokahi Therapeutics Inc.

Glucotrack, Inc. signed an agreement for Lokahi Therapeutics Inc.

Buy side: Glucotrack, Inc.
Buy sideGlucotrack, Inc.
Target: Lokahi Therapeutics Inc.
TargetLokahi Therapeutics Inc.
Glucotrack, Inc. · 14 Jul 2026Source
Buy side: Glucotrack, Inc.
Buy sideGlucotrack, Inc.
Target: Lokahi Therapeutics Inc.
TargetLokahi Therapeutics Inc.
01 / BuyerGlucotrack, Inc.
02 / TargetLokahi Therapeutics Inc.
Source for the buyer and target: Glucotrack, Inc.

For the buyer and target.

“On July 14, 2026 (the “Closing Date”), Glucotrack, Inc., a Delaware corporation (the “Acquiror”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Glucotrack Merger Sub, Inc., a Nevada corporation (“Merger Sub”), Lokahi Therapeutics, Inc., a Nevada corporation, Glucotrack Technologies Inc. (“Operating Sub”), and Paul V. Goode, solely in his capacity as representative for the Operating Sub (the “Operating Sub Representative”).”

Published 28 Aug 2026

Open the source
01

What happened

The deal for Lokahi Therapeutics Inc. is signed, with Glucotrack, Inc. as the buyer. [01]

The filing from Glucotrack, Inc. is dated Aug. 28, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Glucotrack, Inc.

Glucotrack, Inc. signed an agreement for Lokahi Therapeutics Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Glucotrack, Inc.

    The source this page is built from.

    Open the source
  2. Announced

    “The filing from Glucotrack, Inc. is dated Aug. 28, 2026”

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.